ArticleCureus2024

Combination Therapy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel for Metastatic Non-squamous Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Resistance and EGFR Mutations.

Hironori Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.